SCHEMBL21615972

SCHEMBL21615972

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3sc4ccc5oc6ccccc6c5c4c3c2)cc1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.31
▸ PLA2G2A P14555 1/20 0.31
▸ PLA2G4A P47712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21615975 0.96 — —
SCHEMBL21616004 0.95 — —
SCHEMBL21615959 0.95 — —
SCHEMBL21615983 0.95 KDM4E (0.30) —
SCHEMBL21615980 0.93 KDM4E (0.32) —
SCHEMBL21615977 0.93 — —
SCHEMBL21615988 0.92 — —
SCHEMBL21615978 0.92 — —
SCHEMBL21616007 0.91 KDM4E (0.32) —
SCHEMBL21615951 0.91 LIMK1 (0.30) LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787818-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-17 — — US disclosed
US-11787818-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-17 — — US disclosed
US-20210206778-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-07-08 — — US disclosed
WO-2020009442-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787818-B2 Compound and organic light emitting device comprising the same NCOA4, RCOR1, NR2E3 LIMK1 1400/4885PLA2G2A 4006/4885PLA2G4A 3752/4885
US-20210206778-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NCOA4, NR2E3, NR4A1 LIMK1 1399/4885PLA2G2A 3670/4885PLA2G4A 3410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback